Resverlogix (TSE:RVX) Hits New 12-Month Low – Time to Sell?

by · The Markets Daily

Resverlogix Corp. (TSE:RVX – Get Free Report)’s share price hit a new 52-week low during trading on Tuesday. The company traded as low as C$0.07 and last traded at C$0.07, with a volume of 2,850 shares traded. The stock had previously closed at C$0.07.

Resverlogix Stock Down 12.5%

The firm has a fifty day moving average of C$0.09 and a 200 day moving average of C$0.10. The company has a quick ratio of 0.04, a current ratio of 0.04 and a debt-to-equity ratio of -82.47. The stock has a market cap of C$24.10 million, a PE ratio of -1.75 and a beta of -0.36.

About Resverlogix

(Get Free Report)

Founded in 2001, Resverlogix is a Calgary based late-stage biotechnology company, and a world leader in epigenetics, with the goal of developing first-in-class therapies for the benefit of patients with chronic disease. Resverlogix is developing a new class of epigenetic therapies designed to regulate the expression of disease-causing genes. We aim to improve patients’ lives by restoring biological functions – altered by serious illnesses such as cardiovascular disease – back to a healthier state.

Recommended Stories